Olivia Belbin

4.6k total citations · 1 hit paper
51 papers, 1.4k citations indexed

About

Olivia Belbin is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Olivia Belbin has authored 51 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Physiology, 21 papers in Molecular Biology and 12 papers in Cellular and Molecular Neuroscience. Recurrent topics in Olivia Belbin's work include Alzheimer's disease research and treatments (32 papers), Genetic Associations and Epidemiology (8 papers) and Dementia and Cognitive Impairment Research (8 papers). Olivia Belbin is often cited by papers focused on Alzheimer's disease research and treatments (32 papers), Genetic Associations and Epidemiology (8 papers) and Dementia and Cognitive Impairment Research (8 papers). Olivia Belbin collaborates with scholars based in Spain, United States and United Kingdom. Olivia Belbin's co-authors include Alberto Lleó, Jordi Clarimón, Juan Fortea, Jordi Pegueroles, Martí Colom‐Cadena, Kevin Morgan, Rafael Blesa, Daniel Alcolea, Neill R. Graff‐Radford and Talisha A. Hunter and has published in prestigious journals such as Nature Medicine, PLoS ONE and Scientific Reports.

In The Last Decade

Olivia Belbin

49 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease

2024 140 citations Juan Fortea, Jordi Pegueroles et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Olivia Belbin Spain	18	875	550	264	263	248	51	1.4k
Chang‐En Yu United States	18	840 1.0×	713 1.3×	193 0.7×	241 0.9×	223 0.9×	30	1.5k
Kensaku Kasuga Japan	19	572 0.7×	420 0.8×	203 0.8×	177 0.7×	386 1.6×	74	1.2k
Caroline Van Cauwenberghe Belgium	17	860 1.0×	700 1.3×	385 1.5×	149 0.6×	137 0.6×	22	1.6k
Ivan Milenković Austria	22	537 0.6×	573 1.0×	287 1.1×	181 0.7×	394 1.6×	49	1.6k
Diego Sepúlveda‐Falla Germany	18	884 1.0×	579 1.1×	344 1.3×	235 0.9×	189 0.8×	46	1.4k
Muhammad Omar Chohan United States	19	888 1.0×	587 1.1×	214 0.8×	104 0.4×	202 0.8×	47	1.8k
Susanna Schraen‐Maschke France	25	1.2k 1.3×	812 1.5×	387 1.5×	468 1.8×	347 1.4×	66	2.0k
Liana Fidani Greece	18	1.3k 1.5×	927 1.7×	258 1.0×	204 0.8×	458 1.8×	74	2.2k
Andrea Tedde Italy	24	490 0.6×	455 0.8×	96 0.4×	157 0.6×	201 0.8×	67	1.3k
Karolien Bettens Belgium	18	839 1.0×	616 1.1×	316 1.2×	159 0.6×	129 0.5×	24	1.4k

Countries citing papers authored by Olivia Belbin

Since Specialization

Citations

This map shows the geographic impact of Olivia Belbin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivia Belbin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivia Belbin more than expected).

Fields of papers citing papers by Olivia Belbin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivia Belbin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivia Belbin. The network helps show where Olivia Belbin may publish in the future.

Co-authorship network of co-authors of Olivia Belbin

This figure shows the co-authorship network connecting the top 25 collaborators of Olivia Belbin. A scholar is included among the top collaborators of Olivia Belbin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivia Belbin. Olivia Belbin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barba, Lorenzo, Giovanni Bellomo, Daniel Alcolea, et al.. (2025). Serum level changes of the synaptic marker beta-synuclein in Alzheimer’s disease continuum and other dementias. Journal of Neurology Neurosurgery & Psychiatry. 96(12). jnnp–2025.

Colom‐Cadena, Martí, Jordi Pegueroles, Àlex Bayés, et al.. (2025). Enhancing Lateral Resolution Using Two‐Colour Direct Stochastic Optical Reconstruction Microscopy to Unravel Synaptic Tau Pathology in Alzheimer's Disease. Neuropathology and Applied Neurobiology. 51(2). e70010–e70010. 2 indexed citations

Fortea, Juan, Jordi Pegueroles, Daniel Alcolea, et al.. (2024). APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease. Nature Medicine. 30(5). 1284–1291. 140 indexed citations breakdown →

Núñez‐Llaves, Raúl, et al.. (2024). Synapse‐enriched miRNA expression in Alzheimer’s disease cortex tissue. Alzheimer s & Dementia. 20(S1). e090741–e090741. 1 indexed citations

Goossens, Julie, Juan Fortea, Daniel Alcolea, et al.. (2023). Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum. Alzheimer s Research & Therapy. 15(1). 186–186. 11 indexed citations

Querol‐Vilaseca, Marta, Raúl Núñez‐Llaves, Jordi Pegueroles, et al.. (2023). Amyloid precursor protein 𝛽CTF accumulates in synapses in sporadic and genetic forms of Alzheimer's disease. Neuropathology and Applied Neurobiology. 49(1). e12879–e12879. 5 indexed citations

Delaby, Constance, Daniel Alcolea, Christophe Hirtz, et al.. (2022). Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles. Journal of Neural Transmission. 129(2). 231–237. 16 indexed citations

Belbin, Olivia, et al.. (2022). Fluid markers of synapse degeneration in synucleinopathies. Journal of Neural Transmission. 129(2). 187–206. 6 indexed citations

Goossens, Julie, MHD Rami Al Shweiki, Steffen Halbgebauer, et al.. (2022). Glutamate receptor 4 as a fluid biomarker for the diagnosis of psychiatric disorders. Journal of Psychiatric Research. 156. 390–397. 5 indexed citations

10.

Irwin, David J., Daniel Alcolea, Corey T. McMillan, et al.. (2022). Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration. Molecular Neurodegeneration. 17(1). 29–29. 9 indexed citations

11.

Dols‐Icardo, Oriol, Víctor Montal, Sònia Sirisi, et al.. (2020). Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosis. Neurology Neuroimmunology & Neuroinflammation. 7(5). 57 indexed citations

12.

Querol‐Vilaseca, Marta, Martí Colom‐Cadena, Jordi Pegueroles, et al.. (2019). Nanoscale structure of amyloid-β plaques in Alzheimer’s disease. Scientific Reports. 9(1). 5181–5181. 58 indexed citations

13.

Yanez, Maria, Olivia Belbin, Lisbell D. Estrada, et al.. (2016). c-Abl links APP-BACE1 interaction promoting APP amyloidogenic processing in Niemann-Pick type C disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1862(11). 2158–2167. 19 indexed citations

14.

Zou, Fanggeng, Olivia Belbin, Minerva M. Carrasquillo, et al.. (2013). Linking Protective GAB2 Variants, Increased Cortical GAB2 Expression and Decreased Alzheimer’s Disease Pathology. PLoS ONE. 8(5). e64802–e64802. 12 indexed citations

15.

Shi, Hui, Olivia Belbin, Christopher Medway, et al.. (2012). Genetic variants influencing human aging from late-onset Alzheimer's disease (LOAD) genome-wide association studies (GWAS). Neurobiology of Aging. 33(8). 1849.e5–1849.e18. 39 indexed citations

16.

Carrasquillo, Minerva M., Olivia Belbin, Talisha A. Hunter, et al.. (2011). Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study. Molecular Neurodegeneration. 6(1). 54–54. 58 indexed citations

17.

Allen, Mariet, Claire Cox, Olivia Belbin, et al.. (2010). Association and heterogeneity at the GAPDH locus in Alzheimer's disease. Neurobiology of Aging. 33(1). 203.e25–203.e33. 19 indexed citations

18.

Carrasquillo, Minerva M., Olivia Belbin, Talisha A. Hunter, et al.. (2010). Replication of CLU, CR1, and PICALM Associations With Alzheimer Disease. Archives of Neurology. 67(8). 961–4. 168 indexed citations

19.

Belbin, Olivia, Helen Beaumont, Donald Warden, et al.. (2008). PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients. Neurobiology of Aging. 30(12). 1992–1999. 12 indexed citations

20.

Belbin, Olivia, J L Dunn, Linda Morgan, et al.. (2007). Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene and the rate of cognitive decline in Alzheimer's disease. Human Molecular Genetics. 16(18). 2199–2208. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact